Li-Chuan Zheng1 article listing Li-Chuan Zheng in Nature Communications, indexed by Paperzzz from Crossref and OSF.Quizartinib and omacetaxine mepesuccinate combination therapy in FLT3-ITD AML: a phase II trial Nature Communications